PAX5 and acute lymphoblastic leukemia: This aberrant dependency on IL-7 subsequently results in additional activating somatic mutations in the JAK-STAT (Jak1/3 [20], Sh2b3 [55]) and NRAS signaling pathways, as detected in our genomic analyses of Pax5± BCP-ALL.